Critical in-stent restenosis following fracture of biolimus-eluting stent: A report of 2 cases

Journal of Invasive Cardiology

Volumn 25, Issue 1, 2013, Pages

  Hioki, Hirofumi ^a   Kumazaki, Setsuo ^a   Izawa, Atsushi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

acute coronary syndromes; in stent restenosis; interventional cardiology; stent design; stenting

Indexed keywords

NOBORI; TROPONIN T; UMIROLIMUS; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY RECANALIZATION; DISEASE SEVERITY; DRUG ELUTING STENT; FLUOROSCOPY; HUMAN; IN-STENT RESTENOSIS; INFERIOR MYOCARDIAL INFARCTION; INTRAVASCULAR ULTRASOUND; MALE; PERCUTANEOUS CORONARY INTERVENTION; THORAX PAIN;

AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS FAILURE; SIROLIMUS;

EID: 84872345690     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chung WS, Park CS, Seung KB, et al. The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation. Int J Cardiol. 2008;125(3):325-331.
2. Dina OH, Peter GA, Brigita CB, et al. The role of vascular calcification in inducing fatigue and fracture of coronary stents. J Biomed Mater Res. 2012;100(1):292-304.
3. Serikawa T, Kawasaki T, Hoga H. Impressive sirolimus-eluting stent fracture immediately after stent implantation: a case report. Int J Cardiol. 2009;134(3):312-315.
4. Lee MS, Jurewitz D, Aragon J, et al. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cariovasc Interv. 2007;69(3):387-394.
5. Aoki J, Nakazawa G, Tanabe K, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2007;69(3):380-386.
6. Chakravarty T, White AJ, Buch M, et al. Meta-analysis of incidence, clinical characteristics and implications of stent fracture. Am J Cardiol. 2010;106(8):1075-1080.
7. Stone GW, Teirstein PS, Meredith IT, et al. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. J Am Coll Cardiol. 2011;57(16):1700-1708.
8. Freixa X, Almasood AS, Khan SQ, et al. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and silorimus-eluting stents: results of long-term follow-up. Catheter Cardiovasc Interv. 2012;79(4):559-565.